Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Gene therapy using modified blood stem cells helped five adults with severe hemophilia A reach therapeutic levels of clotting ...

Lisa Haubenstock of Truckstop discusses the common tactics of scammers in the freight industry and what types of training and technology can help combat those issues, including the new carrier-vetting ...

Good afternoon, and thank you for joining Atlassian's earnings conference call for the second quarter of fiscal year 2025. As ...

Good afternoon, and thank you for joining Atlassian's Earnings Conference Call for the Second Quarter of Fiscal Year 2025. As a reminder, this conference call is being recorded and will be available ...

The Purdy family is working with researchers to develop an entirely new clinical trial they hope will save Paxton and other ...

With a new found sense of tension, and showpiece Contract missions, Citizen Sleeper is transformed. This follow-up has ...